Adalimumab vs Belantamab Mafodotin

## Adalimumab vs Belantamab Mafodotin: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Belantamab Mafodotin**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Belantamab Mafodotin — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Belantamab Mafodotin — Antibody drug conjugate.